Parvovirus B19 (Human), IgG/IgM

Alphabetical Test listing

Parvovirus B19 (Human), IgG/IgM-13537

Parvovirus B19 (Human), IgG/IgM
Human Parvovirus B19, IgG, IgM

Differential diagnosis of acute or recent infection from past infection with human parvovirus associated with erythema infectiosum (fifth disease), aplastic crisis, and fetal infection.

1.0 mL
0.5 mL

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection

Gold serum separator (SST) tube

  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x3

  • Hemolysis
  • Lipemia
  • Gross bacterial contamination
LabCorp Burlington (163303): R-LC
Mo - Fr
5 days

Enzyme immunoassay (EIA)



IgG: < 0.9 index

IgM: < 0.9 index


IgM antibodies are detectable two weeks after exposure. IgG antibody production usually occurs 18 to 24 days after exposure. The presence of IgM antibodies to parvovirus B19 provides definite evidence of recent infection.

86747 x 2
Result 5273-8